Open AccessClinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer
Author(s) -
Daniel Vasile Balaban,
Flavius Ștefan Marin,
George Manucu,
Andreea Zoican,
Marina Ciochina,
Victor Mina,
Cristina Patoni,
Cătălina Vlăduţ,
Săndica Bucurică,
Raluca Costache,
Florentina Ionita-Radu,
Mariana Jinga
Publication year - 2022
Publication title -
world journal of clinical oncology
Language(s) - English
Resource type - Journals
ISSN - 2218-4333
DOI - 10.5306/wjco.v13.i7.630
Subject(s) - medicine , gastroenterology , pancreatic cancer , ca19 9 , cancer , adenocarcinoma , endoscopic ultrasound , pancreatic ductal adenocarcinoma , surgery
Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of death from cancer worldwide. Tumor markers like carbohydrate antigen 19-9 (CA 19-9) have been proven valuable as a diagnostic tool and a predictor for tumor staging and response to therapy.